. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Azetidines/adverse effectsAzetidines/pharmacologyAzetidines/therapeutic useDelayed-Action Preparations/administration & dosageDelayed-Action Preparations/therapeutic useDose-Response Relationship, DrugDrug CombinationsEzetimibeHumansHyperlipidemias/drug therapyHypolipidemic Agents/pharmacologyHypolipidemic Agents/therapeutic useIntestinal Absorption/drug effectsLovastatin/administration & dosageLovastatin/pharmacologyLovastatin/therapeutic useMuscular Diseases/chemically inducedNiacin/administration & dosageNiacin/pharmacologyNiacin/therapeutic use
Substances: See more » AzetidinesDelayed-Action PreparationsDrug CombinationsHypolipidemic Agentslovastatin-niacin combinationNiacinLovastatinEzetimibe
Year: 2003 PMID: 12612501
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN: 0025-732X Impact factor: 1.909